EDITORIAL
Published on 07 Mar 2022
Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy
doi 10.3389/fonc.2022.872300
- 708 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-Leukemia and Lymphoma Immune Therapy
Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-Leukemia and Lymphoma Immune Therapy
8,345
Total downloads
29k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 27 Jan 2022
Comparison of Laboratory Methods for the Clinical Follow Up of Checkpoint Blockade Therapies in Leukemia: Current Status and Challenges Ahead
doi 10.3389/fonc.2022.789728
- 1,379 views
- 3 citations
REVIEW
Published on 10 Nov 2021
The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
doi 10.3389/fonc.2021.767026
- 8,003 views
- 32 citations
ORIGINAL RESEARCH
Published on 08 Oct 2021
Higher TOX Genes Expression Is Associated With Poor Overall Survival for Patients With Acute Myeloid Leukemia
doi 10.3389/fonc.2021.740642
- 3,597 views
- 18 citations
REVIEW
Published on 30 Sep 2021
TIM-3 in Leukemia; Immune Response and Beyond
doi 10.3389/fonc.2021.753677
- 9,459 views
- 44 citations
CASE REPORT
Published on 16 Sep 2021
Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review
doi 10.3389/fonc.2021.726134
- 2,677 views
- 12 citations
Published in
Frontiers in Oncology
- Hematologic Malignancies
Impact
- 29kTopic views
- 20kArticle views
- 8,345Article downloads